Cho Lieu J E, Muntz H R, Prater D, Blount Stahl M
Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, CT, USA.
Int J Pediatr Otorhinolaryngol. 1999 Nov 5;50(3):197-203. doi: 10.1016/s0165-5876(99)00245-1.
Early vocalization and speech production remains a goal in children who require tracheotomy for airway obstruction or chronic ventilation. Although studies document the efficacy of the Passy-Muir valve (PMV) in adults, none have reviewed its efficacy in children. We performed this study to better understand the clinical complexity of its use in children.
Retrospective evaluation of 55 consecutive cases of children with tracheotomy using the PMV.
The children ranged in age from 3 days to 18 years at the time of their tracheotomies, and nearly half were 12 months old or younger. Successful use often requires patient and family conditioning. Overall, 52 children out of the 55 who were evaluated as candidates for the PMV tolerated its use. Many required two or more trials prior to the patient and family being comfortable with its use.
The PMV may be used successfully in children with a variety of airway pathologies as well as diverse medical problems. Discussed is the current protocol for the evaluation of the patient and the introduction of the valve.
对于因气道阻塞或慢性通气而需要进行气管切开术的儿童来说,早期发声和言语产生仍然是一个目标。尽管有研究记录了帕西-缪尔瓣膜(PMV)在成人中的疗效,但尚无研究评估其在儿童中的疗效。我们开展这项研究是为了更好地了解其在儿童中使用的临床复杂性。
对连续55例使用PMV进行气管切开术的儿童病例进行回顾性评估。
这些儿童在接受气管切开术时年龄从3天到18岁不等,近一半儿童年龄在12个月及以下。成功使用通常需要患者及其家属适应。总体而言,55名被评估为适合使用PMV的儿童中,有52名能够耐受其使用。许多儿童在患者及其家属适应其使用之前需要进行两次或更多次尝试。
PMV可成功用于患有各种气道病变以及多种医疗问题的儿童。文中讨论了当前评估患者和引入该瓣膜的方案。